Log in
NASDAQ:ADAP

Adaptimmune Therapeutics Insider Trades

$4.51
-0.02 (-0.44 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.26
Now: $4.51
$4.64
50-Day Range
$4.30
MA: $7.62
$10.78
52-Week Range
$0.71
Now: $4.51
$13.40
Volume1.15 million shs
Average Volume1.54 million shs
Market Capitalization$586.80 million
P/E RatioN/A
Dividend YieldN/A
Beta2.13

Insider Trades

Adaptimmune Therapeutics (NASDAQ:ADAP) Insider Buying and Selling Activity

Insider Ownership Percentage: 18.89%
Insider Buying (Last 12 Months): $5,102,841.00
Insider Selling (Last 12 Months): $6,206,531.03

Insider Buying and Selling by Quarter


Adaptimmune Therapeutics (NASDAQ ADAP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/1/2020Adrian RawcliffeCEOSell2,776$8.51$23,623.76  
8/3/2020Adrian RawcliffeCEOSell2,788$9.25$25,789.00  
8/3/2020John LungerInsiderSell4,823$9.25$44,612.75  
6/29/2020Gavin WoodCFOBuy33,000$1.62$53,460.0033,000  
6/9/2020Lawrence M. AllevaDirectorBuy12,900$1.89$24,381.00  
5/29/2020James NobleDirectorSell500,000$9.33$4,665,000.00  
1/24/2020Peter W SonsiniMajor ShareholderBuy7,500,000$0.67$5,025,000.00  
1/14/2020Adrian RawcliffeCEOSell3,236$5.13$16,600.68  
1/14/2020Elliot NorryInsiderSell911$5.13$4,673.43  
1/14/2020William C. Bertrand, Jr.COOSell2,397$5.13$12,296.61  
1/13/2020James NobleDirectorSell300,000$4.67$1,401,000.00  
1/6/2020Adrian RawcliffeCEOSell5,900$1.20$7,080.00  
1/6/2020John LungerInsiderSell1,148$1.20$1,377.60  
1/6/2020William C. Bertrand, Jr.COOSell3,731$1.20$4,477.20  
8/6/2019Rafael AmadoInsiderSell11,043$2.06$22,748.58  
1/14/2019Adrian RawcliffeCFOSell3,084$5.37$16,561.08  
1/14/2019Gwendolyn Knowlt Binder-SchollCTOSell1,514$5.37$8,130.18  
1/14/2019Rafael AmadoInsiderSell3,028$5.37$16,260.36  
1/14/2019William C. Bertrand, Jr.COOSell2,271$5.37$12,195.27  
12/17/2018Lawrence M. AllevaDirectorBuy47,280$0.84$39,715.20  
10/1/2018Gwendolyn Knowlt Binder-SchollInsiderSell25,000$13.79$344,750.00  
9/7/2018Ali BehbahaniDirectorBuy12,000,000$1.67$20,040,000.00  
9/7/2018Enterprise Associates 14 NewMajor ShareholderBuy3,000,000$1.67$5,010,000.00  
8/29/2018Gwendolyn Knowlt Binder-SchollInsiderSell25,000$10.25$256,250.00  
6/6/2018Orbimed Advisors LlcDirectorSell18,700$13.56$253,572.00  
6/4/2018Peter A ThompsonDirectorSell17,100$13.57$232,047.00  
6/1/2018Orbimed Advisors LlcDirectorSell171,000$13.51$2,310,210.00  
5/30/2018Peter A ThompsonDirectorSell121,000$13.52$1,635,920.00  
5/14/2018Peter A ThompsonDirectorSell10,300$13.50$139,050.00  
3/29/2018Orbimed Advisors LlcDirectorSell1,048,067$11.50$12,052,770.50  
3/27/2018Enterprise Associates 14 NewMajor ShareholderBuy6,571,164$1.92$12,616,634.88  
3/26/2018David M MottDirectorBuy571,164$1.90$1,085,211.60  
3/23/2018Enterprise Associates 14 NewMajor ShareholderBuy1,268,508$1.91$2,422,850.28  
3/22/2018David M MottDirectorBuy869,574$1.90$1,652,190.60  
3/21/2018Ravi ViswanathanMajor ShareholderBuy104,844$1.81$189,767.64  
3/20/2018Adrian RawcliffeCFOSell600,000$1.71$1,026,000.00  
3/27/2017Enterprise Associates 14 NewMajor ShareholderBuy12,870,000$0.70$9,009,000.00  
3/27/2017Orbimed Advisors LlcDirectorBuy1,190,476$4.20$4,999,999.20  
5/24/2016Orbimed Advisors LlcDirectorBuy1,712,400$10.42$17,843,208.00  
5/19/2016Charles Elliott SigalDirectorBuy15,000$1.56$23,400.0052,938  
5/18/2016Charles Elliott SigalDirectorBuy45,000$1.53$68,850.0052,938  
(Data available from 1/1/2013 forward)
This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.